Unité de Fabrication des Médicaments S.A (BVMT: UMED)

BVMT: UMED Income Statement

Financials in millions TND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	140.96	136	96.36	84.5	91.04	107.21
Other Revenue	0.11	-	-	0.01	-	-
Revenue	141.07	136	96.36	84.51	91.04	107.21
Revenue Growth (YoY)	22.48%	41.14%	14.02%	-7.18%	-15.07%	23.10%
Cost of Revenue	63.09	61.72	46.8	38.22	43.69	48.54
Gross Profit	77.98	74.29	49.56	46.29	47.35	58.67
Selling, General & Admin	20.87	19.71	16.77	15.48	15.1	14.99
Other Operating Expenses	10.03	9.88	8.27	6.87	8.37	7.72
Operating Expenses	47.4	45.18	35.95	32.55	34.03	29.86
Operating Income	30.57	29.11	13.61	13.74	13.33	28.8
Interest Expense	-6.48	-6.22	-3.6	-2.63	-3.74	-3.93
Interest & Investment Income	0.05	0.09	0.19	0.28	0.01	0.01
Currency Exchange Gain (Loss)	-0.48	-0.48	-0.05	-0.48	0.33	-1.73
Other Non Operating Income (Expenses)	-11.26	-11.3	-0.22	-0.45	-0.69	-1.07
EBT Excluding Unusual Items	12.41	11.21	9.94	10.47	9.23	22.08
Gain (Loss) on Sale of Assets	0.08	0.08	0.09	0.04	0.08	0.03
Asset Writedown	-0.3	-0.3	-0.2	-0.08	-0.04	-0.01
Pretax Income	12.2	10.99	9.83	10.43	9.27	22.09
Income Tax Expense	5.77	5.45	2	1.72	2.29	4.4
Earnings From Continuing Operations	6.43	5.55	7.83	8.7	6.98	17.69
Net Income	6.43	5.55	7.83	8.7	6.98	17.69
Net Income to Common	6.43	5.55	7.83	8.7	6.98	17.69
Net Income Growth	-50.96%	-29.17%	-10.03%	24.69%	-60.55%	-3.64%
Shares Outstanding (Basic)	-	32	32	32	32	32
Shares Outstanding (Diluted)	-	32	32	32	32	32
EPS (Basic)	-	0.17	0.24	0.27	0.22	0.55
EPS (Diluted)	-	0.17	0.24	0.27	0.22	0.55
EPS Growth	-	-29.17%	-10.03%	24.69%	-60.55%	-3.64%
Free Cash Flow	19.5	18.68	-12.07	15.13	0.08	-3.48
Free Cash Flow Per Share	-	0.58	-0.38	0.47	0.00	-0.11
Dividend Per Share	-	-	0.469	0.406	-	-
Dividend Growth	-	-	15.52%	-	-	-
Gross Margin	55.27%	54.62%	51.43%	54.78%	52.01%	54.72%
Operating Margin	21.67%	21.40%	14.12%	16.26%	14.64%	26.87%
Profit Margin	4.56%	4.08%	8.13%	10.30%	7.67%	16.50%
Free Cash Flow Margin	13.82%	13.73%	-12.52%	17.90%	0.09%	-3.24%
EBITDA	41.49	39.11	23.3	23.02	22.79	35.8
EBITDA Margin	29.41%	28.75%	24.18%	27.24%	25.03%	33.39%
D&A For EBITDA	10.92	10	9.69	9.27	9.46	7
EBIT	30.57	29.11	13.61	13.74	13.33	28.8
EBIT Margin	21.67%	21.40%	14.12%	16.26%	14.64%	26.87%
Effective Tax Rate	47.27%	49.56%	20.35%	16.52%	24.74%	19.92%
Revenue as Reported	141.22	136.15	96.62	84.55	91.07	107.25

Source: S&P Capital IQ. Standard template. Financial Sources.